Suzhou Junjing Biosciences Co., Ltd.

This early-stage study tested a new oral drug called WJ05129 in people with advanced solid tumors that had spread or could not be removed by surgery. The main goals were to find a safe dose, see how the body processes the drug, and check for early signs it might help control the …

This early-stage study tested a new drug called WJ13405 for people with advanced non-small cell lung cancer that had stopped responding to standard treatments. The trial aimed to find a safe dose and see if the drug could help control cancer growth, particularly for patients with…